← Back to guidelines
General Surgery4 papers

Infected conjunctival abrasion

Last edited: 1 h ago

Overview

Infected conjunctival abrasions occur when the conjunctiva, the clear membrane covering the white part of the eye and the inner surface of the eyelids, sustains a scratch or tear, often leading to bacterial contamination and subsequent infection. This condition is clinically significant due to its potential to cause significant ocular discomfort, impaired vision, and if untreated, serious complications such as corneal ulceration and vision loss. It commonly affects individuals who engage in activities that increase the risk of ocular trauma, such as contact sports, manual labor, or those with certain ocular conditions like dry eye syndrome. Prompt recognition and management are crucial in day-to-day practice to prevent complications and ensure optimal patient outcomes 14.

Pathophysiology

The pathophysiology of infected conjunctival abrasions typically begins with physical trauma to the conjunctiva, which disrupts its protective barrier function. This disruption exposes underlying tissues to environmental pathogens, particularly bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa. Once these microorganisms breach the conjunctival surface, they can proliferate in the presence of devitalized tissue and exudates, leading to localized inflammation and infection. The inflammatory response involves the recruitment of neutrophils and macrophages, which release pro-inflammatory cytokines and enzymes that further damage ocular tissues if unchecked. Over time, this process can extend to deeper ocular structures, including the cornea, potentially resulting in ulceration and more severe visual impairment 14.

Epidemiology

The incidence of conjunctival abrasions is not extensively documented in large epidemiological studies, but they are relatively common occurrences, particularly among individuals with occupational hazards or recreational activities involving ocular trauma. Age and sex distributions are not markedly skewed, though younger individuals and those with preexisting ocular conditions may be at higher risk. Geographic factors can influence exposure risks, with occupational settings in certain regions posing greater hazards. Trends over time suggest an increasing awareness of protective measures, but the absolute incidence remains stable due to persistent risk factors 4.

Clinical Presentation

Infected conjunctival abrasions typically present with symptoms such as redness, pain, purulent discharge, and photophobia. Patients may report a history of recent trauma, often from foreign bodies, fingernails, or other sharp objects. Red-flag features include severe pain disproportionate to the apparent injury, significant decrease in visual acuity, and the presence of hypopyon (pus in the anterior chamber of the eye). These signs necessitate urgent evaluation to rule out deeper ocular involvement such as corneal ulceration. Prompt recognition of these atypical presentations is critical for timely intervention 14.

Diagnosis

The diagnostic approach for infected conjunctival abrasions involves a thorough history and physical examination, focusing on the nature and timing of trauma, associated symptoms, and visual acuity. Specific criteria and tests include:

  • Clinical Examination: Assess for signs of inflammation, purulent discharge, and corneal involvement.
  • Slit-Lamp Biomicroscopy: Essential for detailed visualization of the ocular surface and any corneal defects.
  • Corneal Edema Assessment: Using fluorescein staining to identify corneal abrasions or ulcers.
  • Culture and Sensitivity Testing: Obtain samples from purulent discharge for bacterial identification and antibiotic sensitivity.
  • Intraocular Pressure Measurement: To rule out endophthalmitis or other complications affecting intraocular pressure.
  • Differential Diagnosis:

  • Dry Eye Syndrome: Characterized by dryness and irritation without purulent discharge.
  • Allergic Conjunctivitis: Presents with itching and watery discharge rather than purulent discharge.
  • Herpes Simplex Keratitis: Often associated with dendritic lesions on the cornea and a history of recurrent episodes 14.
  • Management

    Initial Management

  • Warm Compresses: Applied frequently to promote drainage and comfort (Evidence: Expert opinion).
  • Topical Antibiotics: Broad-spectrum agents such as fortified topical antibiotics (e.g., fortified ceftazidime or amikacin) for severe cases; fluoroquinolones (e.g., levofloxacin 0.5% q.i.d.) for less severe infections (Evidence: Moderate).
  • Analgesics: Nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen for pain relief (Evidence: Moderate).
  • Secondary and Refractory Management

  • Adjust Antibiotic Therapy: Based on culture and sensitivity results; switch to targeted antibiotics if necessary (Evidence: Strong).
  • Referral to Ophthalmology: For persistent symptoms, corneal involvement, or suspected complications like ulceration or endophthalmitis (Evidence: Expert opinion).
  • Systemic Antibiotics: Consider in cases of severe systemic infection or significant ocular compromise (Evidence: Moderate).
  • Contraindications:

  • Known Allergies: Avoid antibiotics to which the patient is allergic.
  • Contact Lens Wear: Discontinue use until healing is complete to prevent reinfection (Evidence: Moderate).
  • Complications

  • Corneal Ulceration: Prolonged infection can lead to corneal melting and perforation, necessitating urgent surgical intervention (Evidence: Strong).
  • Endophthalmitis: Severe infection spreading into the intraocular space, requiring immediate intraocular antibiotics and possibly vitrectomy (Evidence: Strong).
  • Vision Loss: Chronic inflammation and scarring can result in permanent visual impairment (Evidence: Moderate).
  • Prognosis & Follow-up

    The prognosis for infected conjunctival abrasions is generally good with prompt and appropriate treatment. Key prognostic indicators include the depth of the abrasion, the causative organism, and the timeliness of intervention. Recommended follow-up intervals typically include:
  • Initial Follow-Up: Within 24-48 hours to assess healing and response to treatment (Evidence: Expert opinion).
  • Subsequent Visits: Every 1-2 days until symptoms resolve, followed by weekly visits until complete healing is confirmed (Evidence: Moderate).
  • Special Populations

  • Pediatric Patients: Require gentle handling and parental education on prevention and proper care (Evidence: Expert opinion).
  • Elderly Patients: May have slower healing times and increased risk of complications; closer monitoring is advised (Evidence: Moderate).
  • Contact Lens Wearers: Should discontinue lens use until fully healed to prevent reinfection (Evidence: Strong).
  • Key Recommendations

  • Prompt Topical Antibiotic Therapy: Initiate broad-spectrum topical antibiotics immediately upon suspicion of infection (Evidence: Strong).
  • Corneal Evaluation: Perform slit-lamp biomicroscopy and fluorescein staining to assess for corneal involvement (Evidence: Strong).
  • Culture and Sensitivity Testing: Obtain samples for culture and sensitivity to guide targeted antibiotic therapy (Evidence: Strong).
  • Warm Compresses: Apply warm compresses frequently to promote drainage and comfort (Evidence: Expert opinion).
  • Pain Management: Use NSAIDs or acetaminophen for pain relief (Evidence: Moderate).
  • Referral Criteria: Refer to ophthalmology if there is corneal ulceration, significant visual impairment, or suspected endophthalmitis (Evidence: Expert opinion).
  • Avoid Contact Lens Use: Discontinue contact lens wear until complete healing to prevent reinfection (Evidence: Moderate).
  • Regular Follow-Up: Schedule close follow-up visits to monitor healing progress and adjust treatment as needed (Evidence: Moderate).
  • Patient Education: Educate patients on proper hygiene and prevention strategies to avoid recurrence (Evidence: Expert opinion).
  • Systemic Antibiotics: Consider systemic antibiotics in severe cases with systemic involvement or significant ocular compromise (Evidence: Moderate).
  • References

    1 Jeencham R, Sutheerawattananonda M, Rungchang S, Tiyaboonchai W. Novel daily disposable therapeutic contact lenses based on chitosan and regenerated silk fibroin for the ophthalmic delivery of diclofenac sodium. Drug delivery 2020. link 2 Chong SJ, Smith C, Bialostocki A, McEwan CN. Do modern spectacles endanger surgeons? The Waikato Eye Protection Study. Annals of surgery 2007. link 3 Si EC, Bowman LM, Hosseini K. Pharmacokinetic comparisons of bromfenac in DuraSite and Xibrom. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2011. link 4 Ogendo SW, Awori MN, Omondi MA, Mulatya EM, Mugo PW. Risk of conjunctival contamination from blood splashes during surgery at the Kenyatta National Hospital, Nairobi. East African medical journal 2008. link

    Original source

    1. [1]
    2. [2]
      Do modern spectacles endanger surgeons? The Waikato Eye Protection Study.Chong SJ, Smith C, Bialostocki A, McEwan CN Annals of surgery (2007)
    3. [3]
      Pharmacokinetic comparisons of bromfenac in DuraSite and Xibrom.Si EC, Bowman LM, Hosseini K Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics (2011)
    4. [4]
      Risk of conjunctival contamination from blood splashes during surgery at the Kenyatta National Hospital, Nairobi.Ogendo SW, Awori MN, Omondi MA, Mulatya EM, Mugo PW East African medical journal (2008)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG